TopTier Wealth Management’s Globus Medical GMED Stock Holding History

TopTier Wealth Management’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9	Closed	-$775	–	372
2026 Q1	$775	Buy	+9	New	+$808	﹤0.01%	533

Other funds holding GMED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

TopTier Wealth Management's GMED Position: Q2 2026 in Review

TopTier Wealth Management sold out of Globus Medical (GMED) in Q2 2026, closing a stake of 9 shares — an estimated $775 sold.

TopTier Wealth Management first reported a position in GMED in Q1 2026 and held it in 1 quarter. The position peaked at $775 in Q1 2026. 596 funds tracked by Wall St. Rank hold GMED as of Q2 2026.

TopTier Wealth Management reported no remaining Globus Medical position as of Q2 2026 after selling out during the quarter.
TopTier Wealth Management sold 9 Globus Medical shares in Q2 2026, an estimated $775.
TopTier Wealth Management first reported a position in Globus Medical in Q1 2026 and held it in 1 quarter.
TopTier Wealth Management's Globus Medical position peaked at $775 in Q1 2026.
596 funds tracked by Wall St. Rank held Globus Medical as of Q2 2026.

Based on TopTier Wealth Management's 13F filing for Q2 2026, filed 14 Jul 2026.